Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations

Xenobiotica

Volumn 41, Issue 6, 2011, Pages 501-510

  Pan, Wei ^a   Song, Im Sook ^a   Shin, Ho Jung ^a   Kim, Min Hye ^a   Choi, Yeong Lim ^a   Lim, Su Jeong ^a   Kim, Woo Young ^a   Lee, Sang Seop ^a   Shin, Jae Gook ^a,b  

^a Inje University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

ASBT; ethnic comparison; Genetic polymorphisms; NTCP; transport activity

Indexed keywords

BILE ACID; MEMBRANE PROTEIN; PROTEIN SLC10A1; PROTEIN SLC10A2; ROSUVASTATIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CONTROLLED STUDY; DNA SEQUENCE; DRUG UPTAKE; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; HAPLOTYPE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; NORTH KOREA; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BILE; FLUOROBENZENES; GENE FREQUENCY; GENOMIC STRUCTURAL VARIATION; HUMANS; LINKAGE DISEQUILIBRIUM; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRIMIDINES; SULFONAMIDES; SYMPORTERS; TAUROCHOLIC ACID;

EID: 79956346067     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2011.555567     Document Type: Article

References (25)

1. Arrese M, Trauner M, Ananthanarayanan M, Pizarro M, Solís N, Accatino L, Soroka C, Boyer JL, Karpen SJ, Miquel JF, Suchy FJ. (2003). Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. J Hepatol 38:148-155. (Pubitemid 36169623)
2. Bhat BG, Rapp SR, Beaudry JA, Napawan N, Butteiger DN, Hall KA, Null CL, Luo Y, Keller BT. (2003). Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/-mice by SC-435. J Lipid Res 44:1614-1621. (Pubitemid 37185871)
3. Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. (1998). Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 274:G157-G169.
4. Criado JJ, Domínguez MF, Medarde M, Fernández ER, Macías RI, Marín JJ. (2000). Structural characterization, kinetic studies, and in vitro biological activity of new cis-diamminebis- cholylglycinate(O,O') Pt(II) and cis-diamminebis-ursodeoxycholate(O,O') Pt(II) complexes. Bioconjug Chem 11:167-174. (Pubitemid 30174483)
5. Dawson PA, Oelkers P. (1995). Bile acid transporters. Curr Opin Lipidol 6:109-114.
6. Deng JW, Shon JH, Shin HJ, Park SJ, Yeo CW, Zhou HH, Song IS, Shin JG. (2008). Efect of silymarin supplement on the pharmacokinetics of rosuvastatin. Pharm Res 25:1807-1814.
7. Gabriel SB, Schafner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. (2002). Te structure of haplotype blocks in the human genome. Science 296:2225-2229. (Pubitemid 34680308)
8. Hagenbuch B, Stieger B, Foguet M, Lübbert H, Meier PJ. (1991). Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sci USA 88:10629-10633. (Pubitemid 21915890)
9. Ho RH, Leake BF, Roberts RL, Lee W, Kim RB. (2004). Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem 279:7213-7222. (Pubitemid 38248869)
10. Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB. (2006). Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130:1793-1806.
11. Holzer A, Harsch S, Renner O, Strohmeyer A, Schimmel S, Wehkamp J, Fritz P, Stange EF. (2008). Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal infammation. Digestion 78:52-59.
12. Huf MW, Telford DE, Edwards JY, Burnett JR, Barrett PH, Rapp SR, Napawan N, Keller BT. (2002). Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB. Arterioscler Tromb Vasc Biol 22:1884-1891. (Pubitemid 35315777)
13. Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA. (2004). Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 53: 78-84. (Pubitemid 38083014)
14. Jung D, Fried M, Kullak-Ublick GA. (2002). Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. J Biol Chem 277:30559-30566. (Pubitemid 34970749)
15. Kang HJ, Song IS, Shin HJ, Kim WY, Lee CH, Shim JC, Zhou HH, Lee SS, Shin JG. (2007). Identifcation and functional characterization of genetic variants of human organic cation transporters in a Korean population. Drug Metab Dispos 35:667-675.
16. Kitamura S, Maeda K, Wang Y, Sugiyama Y. (2008). Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos 36:2014-2023.
17. Love MW, Craddock AL, Angelin B, Brunzell JD, Duane WC, Dawson PA. (2001). Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. Arterioscler Tromb Vasc Biol 21:2039-2045. (Pubitemid 34219759)
18. Mareninova O, Shin JM, Vagin O, Turdikulova S, Hallen S, Sachs G. (2005). Topography of the membrane domain of the liver Na+-dependent bile acid transporter. Biochemistry 44: 13702-13712. (Pubitemid 41507451)
19. Oelkers P, Kirby LC, Heubi JE, Dawson PA. (1997). Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 99:1880-1887. (Pubitemid 27175935)
20. Pourmand N, Elahi E, Davis RW, Ronaghi M. (2002). Multiplex pyrosequencing. Nucleic Acids Res 30:e31.
21. Rausa FM, Tan Y, Zhou H, Yoo KW, Stolz DB, Watkins SC, Franks RR, Unterman TG, Costa RH. (2000). Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes infuence expression of genes involved in bile acid and glucose homeostasis. Mol Cell Biol 20:8264-8282.
22. Renner O, Harsch S, Schaefeler E, Schwab M, Klass DM, Kratzer W, Stange E F. (2009). Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identifed variants linked to reduced expression. Hum Genet 125:381-391.
23. Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, Stofel M. (2001). Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27:375-382. (Pubitemid 32268417)
24. Sundaram U, Wisel S, Stengelin S, Kramer W, Rajendran V. (1998). Mechanism of inhibition of Na+-bile acid cotransport during chronic ileal infammation in rabbits. Am J Physiol 275:G1259-G1265.
25. Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, Denk H, Trauner M. (2003). Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 38:717-727. (Pubitemid 36613336)